Caplin Point Laboratories Limited (CAPLIPOINT.NS)
INR 2396.95
(0.02%)
INR 2396.95
(0.02%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 4.57 Billion INR | 21.48% |
| 2022 | 3.76 Billion INR | 25.49% |
| 2021 | 2.99 Billion INR | 23.76% |
| 2020 | 2.42 Billion INR | 12.68% |
| 2019 | 2.15 Billion INR | 21.77% |
| 2018 | 1.76 Billion INR | 21.95% |
| 2017 | 1.44 Billion INR | 50.57% |
| 2016 | 961.58 Million INR | 57.7% |
| 2015 | 609.75 Million INR | 48.59% |
| 2014 | 410.36 Million INR | 58.76% |
| 2013 | 258.48 Million INR | 84.85% |
| 2012 | 139.83 Million INR | 74.66% |
| 2011 | 80.06 Million INR | 27.45% |
| 2010 | 62.82 Million INR | 88.56% |
| 2009 | 33.31 Million INR | 49.69% |
| 2008 | 22.25 Million INR | 114.95% |
| 2007 | 10.35 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 1.23 Billion INR | 1.97% |
| 2023 Q2 | 1.14 Billion INR | 11.06% |
| 2023 Q3 | 1.17 Billion INR | 2.03% |
| 2023 Q4 | 1.21 Billion INR | 3.74% |
| 2023 Q1 | 1.03 Billion INR | 1.3% |
| 2023 FY | 4.57 Billion INR | 21.48% |
| 2022 Q2 | 916.7 Million INR | 7.86% |
| 2022 Q4 | 1.02 Billion INR | 4.74% |
| 2022 FY | 3.76 Billion INR | 25.49% |
| 2022 Q1 | 849.9 Million INR | 7.5% |
| 2022 Q3 | 974.8 Million INR | 6.34% |
| 2021 Q1 | 708.5 Million INR | 6.74% |
| 2021 Q2 | 749.8 Million INR | 5.83% |
| 2021 Q3 | 749.5 Million INR | -0.04% |
| 2021 Q4 | 790.6 Million INR | 5.48% |
| 2021 FY | 2.99 Billion INR | 23.76% |
| 2020 Q1 | 545.4 Million INR | 11.55% |
| 2020 Q2 | 568.9 Million INR | 4.31% |
| 2020 Q4 | 663.76 Million INR | 2.97% |
| 2020 Q3 | 644.6 Million INR | 13.31% |
| 2020 FY | 2.42 Billion INR | 12.68% |
| 2019 Q4 | 488.94 Million INR | -16.51% |
| 2019 Q1 | 502.34 Million INR | 0.86% |
| 2019 Q2 | 573.18 Million INR | 14.1% |
| 2019 FY | 2.15 Billion INR | 21.77% |
| 2019 Q3 | 585.6 Million INR | 2.17% |
| 2018 Q1 | 374.29 Million INR | 5.86% |
| 2018 Q3 | 458.25 Million INR | 5.33% |
| 2018 Q4 | 498.05 Million INR | 8.69% |
| 2018 FY | 1.76 Billion INR | 21.95% |
| 2018 Q2 | 435.06 Million INR | 16.24% |
| 2017 Q3 | 375.24 Million INR | 5.49% |
| 2017 Q1 | 363.33 Million INR | 8.76% |
| 2017 FY | 1.44 Billion INR | 50.57% |
| 2017 Q4 | 353.57 Million INR | -5.78% |
| 2017 Q2 | 355.71 Million INR | -2.1% |
| 2016 Q1 | 161.36 Million INR | 3.56% |
| 2016 FY | 961.58 Million INR | 57.7% |
| 2016 Q4 | 334.07 Million INR | 39.81% |
| 2016 Q3 | 238.95 Million INR | 5.91% |
| 2016 Q2 | 225.61 Million INR | 39.81% |
| 2015 Q1 | 126.79 Million INR | 19.54% |
| 2015 Q2 | 140.81 Million INR | 11.06% |
| 2015 Q4 | 155.81 Million INR | -3.23% |
| 2015 FY | 609.75 Million INR | 48.59% |
| 2015 Q3 | 161.01 Million INR | 14.34% |
| 2014 Q2 | 86.05 Million INR | 20.53% |
| 2014 Q3 | 91.35 Million INR | 6.16% |
| 2014 FY | 410.36 Million INR | 58.76% |
| 2014 Q1 | 71.39 Million INR | 4.0% |
| 2014 Q4 | 106.06 Million INR | 16.11% |
| 2013 Q2 | 39.66 Million INR | 156.63% |
| 2013 Q4 | 68.65 Million INR | -11.99% |
| 2013 FY | 258.48 Million INR | 84.85% |
| 2013 Q1 | 15.45 Million INR | -54.36% |
| 2013 Q3 | 78 Million INR | 96.66% |
| 2012 Q2 | 54.13 Million INR | 125.36% |
| 2012 Q1 | 24.02 Million INR | 15.42% |
| 2012 Q4 | 33.86 Million INR | -6.9% |
| 2012 FY | 139.83 Million INR | 74.66% |
| 2012 Q3 | 36.37 Million INR | -32.8% |
| 2011 Q2 | 14.8 Million INR | 0.0% |
| 2011 FY | 80.06 Million INR | 27.45% |
| 2011 Q4 | 20.81 Million INR | 1.91% |
| 2011 Q3 | 20.42 Million INR | 37.93% |
| 2010 FY | 62.82 Million INR | 88.56% |
| 2009 FY | 33.31 Million INR | 49.69% |
| 2008 FY | 22.25 Million INR | 114.95% |
| 2007 FY | 10.35 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Sigachi Industries Limited | 571.8 Million INR | -699.385% |
| Ind-Swift Limited | 142.31 Million INR | -3111.864% |
| Bajaj HealthCare Limited | -837.93 Million INR | 645.498% |
| Sakar Healthcare Limited | 116.7 Million INR | -3816.493% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 85.594% |
| Innova Captab Limited | 943.45 Million INR | -384.488% |
| Divi's Laboratories Limited | 16 Billion INR | 71.432% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | -183.01% |
| Morepen Laboratories Limited | 961.59 Million INR | -375.344% |
| Mankind Pharma Limited | 19.12 Billion INR | 76.105% |
| Sequent Scientific Limited | -358.69 Million INR | 1374.332% |
| Wanbury Limited | 559.56 Million INR | -716.87% |
| Laurus Labs Limited | 1.6 Billion INR | -184.703% |
| Nectar Lifesciences Limited | 49.95 Million INR | -9050.951% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 2.93% |
| Alembic Limited | 2.68 Billion INR | -70.163% |
| Hikal Limited | 696 Million INR | -556.739% |
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 25.775% |
| Neuland Laboratories Limited | 3 Billion INR | -52.323% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 17.288% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 130.439% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | -240.021% |
| Themis Medicare Limited | 435.23 Million INR | -950.207% |
| RPG Life Sciences Limited | 876.6 Million INR | -421.435% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 88.157% |
| Lupin Limited | 19.14 Billion INR | 76.125% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -916.374% |
| Wockhardt Limited | -4.63 Billion INR | 198.724% |
| Vaishali Pharma Limited | 7.18 Million INR | -63481.861% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | -110.736% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -1934.857% |
| Jubilant Pharmova Limited | 771 Million INR | -492.853% |
| FDC Limited | 3.05 Billion INR | -49.756% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 91.791% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -3030.453% |
| Eris Lifesciences Limited | 3.91 Billion INR | -16.61% |
| Venus Remedies Limited | 284.9 Million INR | -1504.342% |
| ZIM Laboratories Limited | 172.46 Million INR | -2550.35% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -505.786% |
| Par Drugs and Chemicals Limited | 145.01 Million INR | -3052.127% |
| Shilpa Medicare Limited | 318.74 Million INR | -1334.044% |
| Albert David Limited | 754.2 Million INR | -506.059% |
| Ajanta Pharma Limited | 8.16 Billion INR | 43.996% |
| Hester Biosciences Limited | 188.89 Million INR | -2319.874% |
| Suven Pharmaceuticals Limited | 3 Billion INR | -52.221% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 180.56% |
| Gufic Biosciences Limited | 861.35 Million INR | -430.663% |
| Windlas Biotech Limited | 581.87 Million INR | -685.553% |
| Procter & Gamble Health Limited | 2 Billion INR | -127.431% |
| Aarey Drugs & Pharmaceuticals Limited | 46.83 Million INR | -9659.233% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 5138.637% |
| Granules India Limited | 4.05 Billion INR | -12.775% |
| Aarti Drugs Limited | 1.71 Billion INR | -166.652% |
| Bal Pharma Limited | 73.92 Million INR | -6083.41% |
| Alkem Laboratories Limited | 17.95 Billion INR | 74.546% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 95.227% |
| Lincoln Pharmaceuticals Limited | 933.04 Million INR | -389.889% |
| Medicamen Biotech Limited | 109.31 Million INR | -4081.594% |
| Unichem Laboratories Limited | -704.74 Million INR | 748.591% |
| Bafna Pharmaceuticals Limited | 73.47 Million INR | -6120.689% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -64351.495% |
| Valiant Laboratories Limited | 3.19 Million INR | -142919.399% |
| Orchid Pharma Limited | 921.66 Million INR | -395.939% |
| Medico Remedies Limited | 82.9 Million INR | -5413.153% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | -8.582% |
| Ipca Laboratories Limited | 5.47 Billion INR | 16.49% |
| Brooks Laboratories Limited | -195.91 Million INR | 2433.056% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -1705.666% |
| Piramal Enterprises Limited | -16.83 Billion INR | 127.151% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 72.404% |
| NATCO Pharma Limited | 13.88 Billion INR | 67.076% |
| Suven Life Sciences Limited | -1.05 Billion INR | 535.008% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 2416.914% |
| Strides Pharma Science Limited | -706.14 Million INR | 747.308% |
| Indoco Remedies Limited | 984.6 Million INR | -364.239% |
| Alpa Laboratories Limited | 167.76 Million INR | -2624.585% |
| Lasa Supergenerics Limited | -217.3 Million INR | 2203.439% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 218.046% |